Building Competency in Diabetes Education THE ESSENTIALS

3-48 | CHAPTER 3

REFERENCES

1. Punthakee Z, Goldenberg R, Katz P. Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2018;42(Suppl 1):S10-S15. 2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977-86. 3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. 4. Haire-Joshu D. Management of Diabetes Mellitus: Perspectives of Care Across the Life Span. 2nd ed. St. Louis: Mosby, 1996. 5. Powers AC, Niswender KD, Evans-Molina C. Chapter 396: Diabetes Mellitus: Diagnosis, Classification, and Pathophysiology. In Harrison's Principles of Internal Medicine. 20th ed. New York: McGraw-Hill, 2018. 6. Ruderman AB, Myers MG, Chipkin SR, et al. Hormone-fuel Interrelationship: Fed State, Starvation and Diabetes Mellitus. In Kahn CR, Weir GC, King GL, et al, eds. Joslin’s Diabetes Mellitus . 14th ed. Philadelphia: Lippincott, Williams & Wilkins, 2006:127-44. 7. Leahy JL. β -cell Dysfunction in Type 2 Diabetes. In Kahn CR, Weir GC, King GL, et al, eds. Joslin’s Diabetes Mellitus . 14th ed. Philadelphia: Lippincott, Williams & Wilkins, 2006:449-62. 8. Kruger D, Martin C, Sadler C. New insights into glucose regulation. Diabetes Educ 2006;32:221-7. 9. Owens DR, Zinman B, Bolli GB. Insulins today and beyond. Lancet 2001;358:739-46. 10. Drucker, DJ. The role of gut hormones in glucose homeostasis. The Journal of Clinical Investigation 2007; 17 11. Neumiller JJ, Odegard PS, White JR Jr, et al. Looking to the future: Focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies. Diabetes Educ 2008;34:183 200. 12. Sprague JE, Arbelaez AM. Glucose counterregulatory responses to hypoglycemia. Pediatr. Endocrinol. Rev. 2011; 9(1): 463-475